Serveur d'exploration Hippolyte Bernheim

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular characterization of hepatocellular carcinoma related to hepatitis B virus

Identifieur interne : 000099 ( Hal/Corpus ); précédent : 000098; suivant : 000100

Molecular characterization of hepatocellular carcinoma related to hepatitis B virus

Auteurs : Qian Cao

Source :

RBID : Hal:tel-01126915

Descripteurs français

English descriptors

Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver tumors. Hepatic carcinogenesis is a complex and multifactorial process involving both genetic predisposition (e.g. SNPs) and environmental factors. Nearly 50% of HCC are caused by the hepatitis B virus (HBV) infection worldwide. During HBV infection, multiple genetic and viral alterations accumulate and promote tumor development. By analyzing resected HCC in France, we identified specific molecular features related to HBV infection. First, HBx inactivating mutations are selected in HCC tissues suggesting specific pressure of selection during hepatocarcinogenesis. Second, in patients with a low number of HBV DNA copies per liver cell, we identified additional risk factors like HCV infection, alcohol intake or NASH, suggesting a cooperative effect of these factors with HBV to induce the malignant transformation. Third, TP53 mutations associated with a poor prognostic for HBV infected resected HCC patients. At last, HBV-related tumors demonstrate more frequent progenitor phenotype compared to non-HBV HCC, with an up-regulation of genes that involved in cell cycle regulation and encoded onco-fetal/progenitor proteins. Four SNPs previously identified by genome-wide studies (GWAS) in Asian, have been validated in our European population. Allelic distributions seem to vary according to the etiologies of adjacent liver diseases. These findings underscore the complexity of the genetic predisposition of HCC; further study must consider the geographical origin of patients and associated risk factors.

Url:

Links to Exploration step

Hal:tel-01126915

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular characterization of hepatocellular carcinoma related to hepatitis B virus</title>
<title xml:lang="fr">Caractérisation moléculaire des carcinomes hépatocellulaires liés au virus de l'hépatite B</title>
<author>
<name sortKey="Cao, Qian" sort="Cao, Qian" uniqKey="Cao Q" first="Qian" last="Cao">Qian Cao</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-245900" status="VALID">
<idno type="RNSR">200516360R</idno>
<orgName>Génomique Fonctionnelle des Tumeurs Solides</orgName>
<orgName type="acronym">U1162</orgName>
<date type="start">2014</date>
<desc>
<address>
<addrLine>Bâtiment de l'I.G.M. - 27 Rue Juliette Dodu 75010 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.carpem.fr/activites-scientifiques/les-equipes-scientifiques/equipe-2/</ref>
</desc>
<listRelation>
<relation active="#struct-15786" type="direct"></relation>
<relation name="UMR_S 1162" active="#struct-300301" type="direct"></relation>
<relation name="UMR_S 1162" active="#struct-301664" type="direct"></relation>
<relation name="U1162" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-15786" type="direct">
<org type="institution" xml:id="struct-15786" status="VALID">
<orgName>Université Paris 13</orgName>
<orgName type="acronym">UP13</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris13.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1162" active="#struct-300301" type="direct">
<org type="institution" xml:id="struct-300301" status="VALID">
<orgName>Université Paris Diderot - Paris 7</orgName>
<orgName type="acronym">UPD7</orgName>
<desc>
<address>
<addrLine>5 rue Thomas-Mann - 75205 Paris cedex 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris-diderot.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1162" active="#struct-301664" type="direct">
<org type="institution" xml:id="struct-301664" status="VALID">
<idno type="IdRef">026404788</idno>
<idno type="ISNI">0000 0001 2188 0914 </idno>
<orgName>Université Paris Descartes - Paris 5</orgName>
<orgName type="acronym">UPD5</orgName>
<desc>
<address>
<addrLine>12, rue de l'École de Médecine - 75270 Paris cedex 06</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.parisdescartes.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1162" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-01126915</idno>
<idno type="halId">tel-01126915</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01126915</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-01126915</idno>
<date when="2014-10-02">2014-10-02</date>
<idno type="wicri:Area/Hal/Corpus">000099</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Molecular characterization of hepatocellular carcinoma related to hepatitis B virus</title>
<title xml:lang="fr">Caractérisation moléculaire des carcinomes hépatocellulaires liés au virus de l'hépatite B</title>
<author>
<name sortKey="Cao, Qian" sort="Cao, Qian" uniqKey="Cao Q" first="Qian" last="Cao">Qian Cao</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-245900" status="VALID">
<idno type="RNSR">200516360R</idno>
<orgName>Génomique Fonctionnelle des Tumeurs Solides</orgName>
<orgName type="acronym">U1162</orgName>
<date type="start">2014</date>
<desc>
<address>
<addrLine>Bâtiment de l'I.G.M. - 27 Rue Juliette Dodu 75010 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.carpem.fr/activites-scientifiques/les-equipes-scientifiques/equipe-2/</ref>
</desc>
<listRelation>
<relation active="#struct-15786" type="direct"></relation>
<relation name="UMR_S 1162" active="#struct-300301" type="direct"></relation>
<relation name="UMR_S 1162" active="#struct-301664" type="direct"></relation>
<relation name="U1162" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-15786" type="direct">
<org type="institution" xml:id="struct-15786" status="VALID">
<orgName>Université Paris 13</orgName>
<orgName type="acronym">UP13</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris13.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1162" active="#struct-300301" type="direct">
<org type="institution" xml:id="struct-300301" status="VALID">
<orgName>Université Paris Diderot - Paris 7</orgName>
<orgName type="acronym">UPD7</orgName>
<desc>
<address>
<addrLine>5 rue Thomas-Mann - 75205 Paris cedex 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris-diderot.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1162" active="#struct-301664" type="direct">
<org type="institution" xml:id="struct-301664" status="VALID">
<idno type="IdRef">026404788</idno>
<idno type="ISNI">0000 0001 2188 0914 </idno>
<orgName>Université Paris Descartes - Paris 5</orgName>
<orgName type="acronym">UPD5</orgName>
<desc>
<address>
<addrLine>12, rue de l'École de Médecine - 75270 Paris cedex 06</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.parisdescartes.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1162" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Hepatitis B virus</term>
<term>Hepatocellular carcinoma</term>
<term>Onco-fœtal gene</term>
</keywords>
<keywords scheme="mix" xml:lang="fr">
<term>Carcinome hépatocellulaire</term>
<term>Gène onco-fœtal</term>
<term>HBx</term>
<term>SNPs</term>
<term>TP53</term>
<term>Virus de l’hépatite B</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Hepatocellular carcinoma (HCC) is the most common primary liver tumors. Hepatic carcinogenesis is a complex and multifactorial process involving both genetic predisposition (e.g. SNPs) and environmental factors. Nearly 50% of HCC are caused by the hepatitis B virus (HBV) infection worldwide. During HBV infection, multiple genetic and viral alterations accumulate and promote tumor development. By analyzing resected HCC in France, we identified specific molecular features related to HBV infection. First, HBx inactivating mutations are selected in HCC tissues suggesting specific pressure of selection during hepatocarcinogenesis. Second, in patients with a low number of HBV DNA copies per liver cell, we identified additional risk factors like HCV infection, alcohol intake or NASH, suggesting a cooperative effect of these factors with HBV to induce the malignant transformation. Third, TP53 mutations associated with a poor prognostic for HBV infected resected HCC patients. At last, HBV-related tumors demonstrate more frequent progenitor phenotype compared to non-HBV HCC, with an up-regulation of genes that involved in cell cycle regulation and encoded onco-fetal/progenitor proteins. Four SNPs previously identified by genome-wide studies (GWAS) in Asian, have been validated in our European population. Allelic distributions seem to vary according to the etiologies of adjacent liver diseases. These findings underscore the complexity of the genetic predisposition of HCC; further study must consider the geographical origin of patients and associated risk factors.</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Molecular characterization of hepatocellular carcinoma related to hepatitis B virus</title>
<title xml:lang="fr">Caractérisation moléculaire des carcinomes hépatocellulaires liés au virus de l'hépatite B</title>
<author role="aut">
<persName>
<forename type="first">Qian</forename>
<surname>Cao</surname>
</persName>
<idno type="halauthorid">1063577</idno>
<affiliation ref="#struct-245900"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2015-03-06 22:50:40</date>
<date type="whenModified">2017-12-18 10:04:02</date>
<date type="whenReleased">2015-03-12 14:07:53</date>
<date type="whenProduced">2014-10-02</date>
<date type="whenEndEmbargoed">2015-03-06</date>
<ref type="file" target="https://tel.archives-ouvertes.fr/tel-01126915/document">
<date notBefore="2015-03-06"></date>
</ref>
<ref type="file" subtype="author" n="1" target="https://tel.archives-ouvertes.fr/tel-01126915/file/2014PA05S010.pdf">
<date notBefore="2015-03-06"></date>
</ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="131274">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">tel-01126915</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01126915</idno>
<idno type="halBibtex">cao:tel-01126915</idno>
<idno type="halRefHtml">Hématologie. Université René Descartes - Paris V, 2014. Français. 〈NNT : 2014PA05S010〉</idno>
<idno type="halRef">Hématologie. Université René Descartes - Paris V, 2014. Français. 〈NNT : 2014PA05S010〉</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="STAR">STAR - Dépôt national des thèses électroniques</idno>
<idno type="stamp" n="UNIV-PARIS7">Université Denis Diderot - Paris VII</idno>
<idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
<idno type="stamp" n="UNIV-PARIS5">Université Paris Descartes (Paris 5)</idno>
<idno type="stamp" n="UNIV-PARIS13">Université Paris-Nord - Paris XIII</idno>
<idno type="stamp" n="USPC">Université Sorbonne Paris Cité</idno>
<idno type="stamp" n="THESES-P5" p="UNIV-PARIS5">Thèses de l'Université Paris Descartes</idno>
</seriesStmt>
<notesStmt></notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Molecular characterization of hepatocellular carcinoma related to hepatitis B virus</title>
<title xml:lang="fr">Caractérisation moléculaire des carcinomes hépatocellulaires liés au virus de l'hépatite B</title>
<author role="aut">
<persName>
<forename type="first">Qian</forename>
<surname>Cao</surname>
</persName>
<idno type="halauthorid">1063577</idno>
<affiliation ref="#struct-245900"></affiliation>
</author>
</analytic>
<monogr>
<idno type="nnt">2014PA05S010</idno>
<imprint>
<date type="dateDefended">2014-10-02</date>
</imprint>
<authority type="institution">Université René Descartes - Paris V</authority>
<authority type="school">École doctorale Biologie et biotechnologie (1997-2014 ; Paris)</authority>
<authority type="supervisor">Jessica Zucman-Rossi</authority>
<authority type="jury">Pierre Laurent-Puig [Président]</authority>
<authority type="jury">Jean-Claude Trinchet [Rapporteur]</authority>
<authority type="jury">Gilbert Faure [Rapporteur]</authority>
<authority type="jury">Pierre Nahon</authority>
</monogr>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="fr">French</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">Onco-fœtal gene</term>
<term xml:lang="en">Hepatitis B virus</term>
<term xml:lang="en">Hepatocellular carcinoma</term>
<term xml:lang="fr">SNPs</term>
<term xml:lang="fr">Gène onco-fœtal</term>
<term xml:lang="fr">Carcinome hépatocellulaire</term>
<term xml:lang="fr">Virus de l’hépatite B</term>
<term xml:lang="fr">TP53</term>
<term xml:lang="fr">HBx</term>
</keywords>
<classCode scheme="halDomain" n="sdv.mhep.hem">Life Sciences [q-bio]/Human health and pathology/Hematology</classCode>
<classCode scheme="halTypology" n="THESE">Theses</classCode>
</textClass>
<abstract xml:lang="en">Hepatocellular carcinoma (HCC) is the most common primary liver tumors. Hepatic carcinogenesis is a complex and multifactorial process involving both genetic predisposition (e.g. SNPs) and environmental factors. Nearly 50% of HCC are caused by the hepatitis B virus (HBV) infection worldwide. During HBV infection, multiple genetic and viral alterations accumulate and promote tumor development. By analyzing resected HCC in France, we identified specific molecular features related to HBV infection. First, HBx inactivating mutations are selected in HCC tissues suggesting specific pressure of selection during hepatocarcinogenesis. Second, in patients with a low number of HBV DNA copies per liver cell, we identified additional risk factors like HCV infection, alcohol intake or NASH, suggesting a cooperative effect of these factors with HBV to induce the malignant transformation. Third, TP53 mutations associated with a poor prognostic for HBV infected resected HCC patients. At last, HBV-related tumors demonstrate more frequent progenitor phenotype compared to non-HBV HCC, with an up-regulation of genes that involved in cell cycle regulation and encoded onco-fetal/progenitor proteins. Four SNPs previously identified by genome-wide studies (GWAS) in Asian, have been validated in our European population. Allelic distributions seem to vary according to the etiologies of adjacent liver diseases. These findings underscore the complexity of the genetic predisposition of HCC; further study must consider the geographical origin of patients and associated risk factors.</abstract>
<abstract xml:lang="fr">Le carcinome hépatocellulaire (CHC) est le plus fréquent des tumeurs primitives du foie. La carcinogenèse hépatique est un processus complexe et multifactoriel qui fait intervenir à la fois des facteurs génétiques de prédisposition (e.g. les SNPs) et environnementaux. Près de 50% des CHC ont pour étiologie une infection par le virus de l'hépatite B (VHB). Au cours de cette infection, de multiples altérations génétiques et virales s'accumulent et favorisent le développement tumoral. Nous avons montré que les CHC liés au VHB présentaient des caractéristiques cliniques et pathologiques différents que ceux d’autres étiologies : 1). Les mutations inactivatrices d’HBx sont sélectionnées dans les tissus tumoraux des CHC liés au VHB, suggérant qu’il existe une pression de sélection spécifique au cours de l’hépatocarcinogenèse. 2). Chez les patients ayant un faible nombre de copies d'ADN VHB par cellule dans le foie non-tumoral, une corrélation avec les facteurs de risque supplémentaires (VHC/OH/NASH) a été identifiée, suggérant un effet coopératif pour la carcinogenèse induite par le VHB. 3). Les mutations TP53 sont associées à un pronostic moins favorable chez les patients ayant un CHC liés au VHB. 4). Les CHC liés au VHB montrent plus fréquemment des phénotypes progéniteurs, avec une surexpression des gènes impliqués dans la régulation du cycle cellulaire et codant pour les protéines onco-fœtales. Quatre SNPs précédemment identifiés par des études pangénomiques (GWAS) asiatiques ont été validés dans la population européenne. Les distributions alléliques semblent varier selon l’étiologie de la pathologie hépatique. Ces résultats soulignent la complexité de la prédisposition génétique au CHC, dont l’étude doit prendre en considération l’origine géographique des patients ainsi que les facteurs de risque associés.</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000099 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000099 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    BernheimV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:tel-01126915
   |texte=   Molecular characterization of hepatocellular carcinoma related to hepatitis B virus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Mar 5 17:33:33 2018. Site generation: Thu Apr 29 15:49:51 2021